tm logo
DRAINAD
Dead/Cancelled
CANCELLED – SECTION 71

on 13 Sep 2024

Last Applicant/ Owned by

22769 Hamburg

DE

Serial Number

79206144 filed on 30th Sep 2016

Registration Number

5409575 registered on 27th Feb 2018

in the Principal Register

Correspondent Address

Suite 2900

Indianapolis, IN 46282

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

DRAINAD

Chemical products for the production of viral, retroviral and non-viral vectors Biochemical and chemical preparations for medical purposes in particular those with the active ingredient thiethylperazine, for use in neurodegenerative diseases; biochemical and chemical preparations for medical purposes in particular those with the active ingredient thiethylperazine, for use in dementia disorders an Read More

Classification Information


Class [005]
Pharmaceutical Products


Biochemical and chemical preparations for medical purposes in particular those with the active ingredient thiethylperazine, for use in neurodegenerative diseases; biochemical and chemical preparations for medical purposes in particular those with the active ingredient thiethylperazine, for use in dementia disorders and their earlier stages, in particular for use in Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for prevention against neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for preventing dementia disorders and their earlier stages, in particular for preventing Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in oral administration form, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of dementia disorders and their earlier stages, in particular for the treatment of Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes in parenteral administration form, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Alzheimer's disease and mild cognitive impairment


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Chemical products for the production of viral, retroviral and non-viral vectors


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79206144

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 61459.4001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Sep 2024CANCELLED SECTION 71
27th Feb 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11th Mar 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
20th Oct 2021NEW REPRESENTATIVE AT IB RECEIVED
26th Jul 2019NEW REPRESENTATIVE AT IB RECEIVED
29th Jun 2018FINAL DECISION TRANSACTION PROCESSED BY IB
04th Jun 2018FINAL DISPOSITION NOTICE SENT TO IB
04th Jun 2018FINAL DISPOSITION PROCESSED
27th May 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27th Feb 2018REGISTERED-PRINCIPAL REGISTER